Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology

BMC Research Notes

Volumn 9, Issue 1, 2016, Pages 1-10

  Oldroyd, J C ^a   Venardos, K M ^a   Aoki, N J ^a   Zatta, A J ^a   McQuilten, Z K ^a   Phillips, L E ^a   Andrianopoulos, N ^a   Cooper, D J ^a   Cameron, P A ^a,b   Isbister, J P ^c   Wood, E M ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Critical bleeding; Massive transfusion; Registry

Indexed keywords

AUSTRALIA; BLOOD BANK; BLOOD TRANSFUSION; HEALTH CARE DELIVERY; HEMORRHAGE; HUMAN; NEW ZEALAND; REGISTER; TREATMENT OUTCOME;

AUSTRALIA; BLOOD BANKS; BLOOD TRANSFUSION; DELIVERY OF HEALTH CARE; HEMORRHAGE; HUMANS; NEW ZEALAND; REGISTRIES; TREATMENT OUTCOME;

EID: 85061424758     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-016-2261-6     Document Type: Article

References (36)

1. Australian Red Cross Blood Service. Adverse events. 2016. http://www.transfusion.com.au/adverse_events_overview. Accessed 5 Mar 2016.
2. Galas FR, Almeida JP, Fukushima JT, Osawa EA, Nakamura RE, Silva CM, de Almeida EP, Auler JO, Vincent JL, Hajjar LA. Blood transfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patients. J Cardiothorac Surg. 2013;8(1):1. doi:10.1186/749-8090-8-54.
3. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for post injury multiple organ failure. Arch Surg. 1997;132(6):620-4.
4. Bolton-Maggs PH, Cohen H. Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol. 2013;163(3):303-14. doi:10.1111/bjh.12547.
5. Dzik WS, Ziman A, Cohen C, Pai M, Lozano M, Kaufman RM, et al. Survival after ultramassive transfusion: a review of 1360 cases. Transfusion. 2015;00:1-6.
6. National blood authority. Patient blood management guidelines: module 1 critical bleeding massive transfusion Canberra. 2011:1-104.
7. Dunn LK, Thiele RH, Ma JZ, Sawyer RG, Nemergut EC. Duration of red blood cell storage and outcomes following orthotopic liver transplantation. Liver Transpl. 2012;18(4):475-81.
8. Stanworth SJ, Morris TP, Gaarder C, Goslings JC, Maegele M, Cohen MJ, et al. Reappraising the concept of massive transfusion in trauma. Crit Care. 2010;14(6):30.
9. Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, et al. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth. 2013;23:23.
10. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang. 2008;95(2):112-9.
11. Sinha R, Roxby D, Bersten A. Experience with a massive transfusion protocol in the management of massive haemorrhage. Transfus Med. 2013;23(2):108-13.
12. Rose AH, Kotze A, Doolan D, Norfolk DR, Bellamy MC. Massive transfusion - evaluation of current clinical practice and outcome in two large teaching hospital trusts in Northern England. Vox Sang. 2009;97(3):247-53.
13. Campos A, Muñoz M, Garcia-Erce JA, Ramirez G. Incidence and mortality of massive transfusion in a university hospital: study of the period 2001-2005. Med Clin. 2007;129(10):366-71.
14. Sinha R, Roxby D. Change in transfusion practice in massively bleeding patients. Transfus Apher Sci. 2011;45(2):171-4.
15. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-82.
16. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015;386(9989):137-44.
17. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.
18. Davenport R, Curry N, Manson J, De’Ath H, Coates A, Rourke C, et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma. 2011;70(1):90-5.
19. Kautza BC, Cohen MJ, Cuschieri J, Minei JP, Brackenridge SC, Maier RV, et al. Changes in massive transfusion over time: an early shift in the right direction? J Trauma Acute Care Surg. 2012;72(1):106-11.
20. Magnotti LJ, Zarzaur BL, Fischer PE, Williams RF, Myers AL, Bradburn EH, et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes? J Trauma. 2011;70(1):97-102.
21. Mitra B, Cameron PA, Gruen RL. Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy. Injury. 2012;43(1):33-7.
22. Pasquier P, Gayat E, Rackelboom T, La Rosa J, Tashkandi A, Tesniere A, et al. An observational study of the fresh frozen plasma: red blood cell ratio in postpartum hemorrhage. Anesth Analg. 2013;116(1):155-61.
23. Review McKeon. Strategic review of health and medical research - better health through research summary report. Canberra: For the Department of Health and Ageing; 2013. p. 1-56.
24. Evans SM, Bohensky M, Cameron PA, McNeil J. A survey of Australian clinical registries: can quality of care be measured? Intern Med J. 2011;41(1a):42-8.
25. Evans SM, Scott IA, Johnson NP, Cameron PA, McNeil JJ. Development of clinical-quality registries in Australia: the way forward. Med J Aust. 2011;194(7):360-3.
26. McNeil JJ, Evans SM, Johnson NP, Cameron PA. Clinical-quality registries: their role in quality improvement. Med J Aust. 2010;192(5):244-5.
27. Australian Institute of Health and Welfare. Australia’s Health System. 2016. http://www.aihw.gov.au/australias-health/2014/health-system/. Accessed 1 Sept 2016.
28. New Zealand Ministry of Health. New Zealand Health System. 2016 http://www.health.govt.nz/new-zealand-health-system. Accessed 1 Sept 2016.
29. Australian Commission on Safety and Quality in Health Care. Operating Principles for Australian Clinical Quality Registries. 2010. http://www.safetyandquality.gov.au/wp-content/uploads/2012/03/Operating-Principles-for-Australian-Clinical-Quality-Registries-Brochure-2011.pdf Accessed 1 Feb 2016.
30. Tu JV, Willison DJ, Silver FL, Fang J, Richards J, Laupacis A, et al. Impracticability of informed consent in the registry of the Canadian stroke network. N Engl J Med. 2004;350:1414-20.
31. Zatta AJ, McQuilten ZK, Mitra B, et al. Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion. Vox Sang. 2014;107(1):60-70.
32. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
33. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.
34. Zatta A, Mcquilten Z, Kandane-Rathnayake R, Isbister J, Dunkley S, McNeil J, Cameron P. L. P. The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus. 2015;13(1):86-99.
35. McQuilten ZK, Schembri N, Polizzotto MN, Akers C, Wills M, Cole-Sinclair MF, Whitehead S, Wood EM, Phillips LE. Hospital blood bank information systems accurately reflect patient transfusion: results of a validation study. Transfusion. 2011;51(5):943-8.
36. Australian Institute of Health and Welfare. Australian hospital peer groups. Health services series no. 66. Cat. no. HSE 170. Canberra: AIHW. 2015. http://www.aihw.gov.au/publication-detail/?id=60129553446. Accessed 1 Sept 2015.